WO2021256826A1 - 기능성 섬유 제조방법 - Google Patents
기능성 섬유 제조방법 Download PDFInfo
- Publication number
- WO2021256826A1 WO2021256826A1 PCT/KR2021/007463 KR2021007463W WO2021256826A1 WO 2021256826 A1 WO2021256826 A1 WO 2021256826A1 KR 2021007463 W KR2021007463 W KR 2021007463W WO 2021256826 A1 WO2021256826 A1 WO 2021256826A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fiber
- plasma
- cold
- plasma chamber
- functional
- Prior art date
Links
- 239000000835 fiber Substances 0.000 title claims abstract description 182
- 238000000034 method Methods 0.000 title claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 19
- 230000005495 cold plasma Effects 0.000 claims abstract description 83
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 47
- 238000009832 plasma treatment Methods 0.000 claims abstract description 47
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 38
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 23
- 125000000864 peroxy group Chemical group O(O*)* 0.000 claims abstract description 18
- 230000000840 anti-viral effect Effects 0.000 claims abstract description 17
- 238000012545 processing Methods 0.000 claims description 58
- 239000007789 gas Substances 0.000 claims description 25
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 22
- 239000001301 oxygen Substances 0.000 claims description 22
- 229910052760 oxygen Inorganic materials 0.000 claims description 22
- -1 polyethylene Polymers 0.000 claims description 18
- 238000002844 melting Methods 0.000 claims description 12
- 230000008018 melting Effects 0.000 claims description 12
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 10
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 229920000728 polyester Polymers 0.000 claims description 9
- 229920000742 Cotton Polymers 0.000 claims description 8
- 239000004698 Polyethylene Substances 0.000 claims description 8
- 239000004743 Polypropylene Substances 0.000 claims description 8
- 229920002334 Spandex Polymers 0.000 claims description 8
- 229920001778 nylon Polymers 0.000 claims description 8
- 229920000573 polyethylene Polymers 0.000 claims description 8
- 229920001155 polypropylene Polymers 0.000 claims description 8
- 239000004759 spandex Substances 0.000 claims description 8
- 239000004677 Nylon Substances 0.000 claims description 7
- 229920002978 Vinylon Polymers 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
- 239000004760 aramid Substances 0.000 claims description 6
- 229920003235 aromatic polyamide Polymers 0.000 claims description 6
- 239000003949 liquefied natural gas Substances 0.000 claims description 6
- 238000010301 surface-oxidation reaction Methods 0.000 claims description 6
- 229910052786 argon Inorganic materials 0.000 claims description 5
- 229910052754 neon Inorganic materials 0.000 claims description 5
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 claims description 5
- 229920001617 Vinyon Polymers 0.000 claims description 4
- 210000000085 cashmere Anatomy 0.000 claims description 4
- 229920000297 Rayon Polymers 0.000 claims description 3
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- 239000002781 deodorant agent Substances 0.000 claims description 3
- 238000006011 modification reaction Methods 0.000 claims description 3
- 239000001294 propane Substances 0.000 claims description 3
- 239000002964 rayon Substances 0.000 claims description 3
- 229940089401 xylon Drugs 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 230000001877 deodorizing effect Effects 0.000 abstract description 17
- 238000005516 engineering process Methods 0.000 abstract description 5
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 abstract 1
- 125000002081 peroxide group Chemical group 0.000 abstract 1
- 239000004744 fabric Substances 0.000 description 47
- 238000004332 deodorization Methods 0.000 description 30
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 27
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 18
- 230000009467 reduction Effects 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 14
- 235000019645 odor Nutrition 0.000 description 14
- 230000003385 bacteriostatic effect Effects 0.000 description 13
- 229920002620 polyvinyl fluoride Polymers 0.000 description 12
- 239000000126 substance Substances 0.000 description 11
- 229910021529 ammonia Inorganic materials 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 9
- 239000002105 nanoparticle Substances 0.000 description 7
- 230000001590 oxidative effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 239000004753 textile Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229910052732 germanium Inorganic materials 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229910002616 GeOx Inorganic materials 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 229910010413 TiO 2 Inorganic materials 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 229910021432 inorganic complex Inorganic materials 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 2
- 239000005543 nano-size silicon particle Substances 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920002577 polybenzoxazole Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 229910052814 silicon oxide Inorganic materials 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- IIEJGTQVBJHMDL-UHFFFAOYSA-N 2-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-5-[2-oxo-2-[3-(sulfamoylamino)pyrrolidin-1-yl]ethyl]-1,3,4-oxadiazole Chemical compound C1CN(CC1NS(=O)(=O)N)C(=O)CC2=NN=C(O2)C3=CN=C(N=C3)NC4CC5=CC=CC=C5C4 IIEJGTQVBJHMDL-UHFFFAOYSA-N 0.000 description 1
- FARHYDJOXLCMRP-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]pyrazol-3-yl]oxyacetic acid Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(N1CC2=C(CC1)NN=N2)=O)OCC(=O)O FARHYDJOXLCMRP-UHFFFAOYSA-N 0.000 description 1
- XYLOFRFPOPXJOQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(piperazine-1-carbonyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound O=C(Cn1cc(c(n1)C(=O)N1CCNCC1)-c1cnc(NC2Cc3ccccc3C2)nc1)N1CCc2n[nH]nc2C1 XYLOFRFPOPXJOQ-UHFFFAOYSA-N 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 229920002748 Basalt fiber Polymers 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229920006231 aramid fiber Polymers 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000012784 inorganic fiber Substances 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- 238000010849 ion bombardment Methods 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- SFMJNHNUOVADRW-UHFFFAOYSA-N n-[5-[9-[4-(methanesulfonamido)phenyl]-2-oxobenzo[h][1,6]naphthyridin-1-yl]-2-methylphenyl]prop-2-enamide Chemical compound C1=C(NC(=O)C=C)C(C)=CC=C1N1C(=O)C=CC2=C1C1=CC(C=3C=CC(NS(C)(=O)=O)=CC=3)=CC=C1N=C2 SFMJNHNUOVADRW-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 150000004965 peroxy acids Chemical group 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M10/00—Physical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. ultrasonic, corona discharge, irradiation, electric currents, or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements
- D06M10/02—Physical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. ultrasonic, corona discharge, irradiation, electric currents, or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements ultrasonic or sonic; Corona discharge
- D06M10/025—Corona discharge or low temperature plasma
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62B—DEVICES, APPARATUS OR METHODS FOR LIFE-SAVING
- A62B18/00—Breathing masks or helmets, e.g. affording protection against chemical agents or for use at high altitudes or incorporating a pump or compressor for reducing the inhalation effort
- A62B18/02—Masks
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M10/00—Physical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. ultrasonic, corona discharge, irradiation, electric currents, or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements
- D06M10/02—Physical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. ultrasonic, corona discharge, irradiation, electric currents, or magnetic fields; Physical treatment combined with treatment with chemical compounds or elements ultrasonic or sonic; Corona discharge
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2401/00—Physical properties
- D10B2401/13—Physical properties anti-allergenic or anti-bacterial
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2403/00—Details of fabric structure established in the fabric forming process
- D10B2403/01—Surface features
Definitions
- the present invention relates to a method for manufacturing a functional fiber, and more particularly, by using cold plasma or thermal plasma to modify the surface of the fiber with oxidizing or peroxidizing groups such as hydroxy groups, carboxyl groups, peroxy acids, siloxanes, etc., deodorizing, antibacterial and antibacterial It relates to the technology that gives the virus function.
- the chemical removal method uses chemical reactions such as neutralization, addition, polymerization, oxidation, reduction, and hydrolysis to act with a substance with strong reactivity on odor components to decompose or change odorless substances into odorless compounds. way to remove it.
- the physicochemical removal method uses a compound with strong adsorption and trapping ability, such as activated carbon, silica, or cyclodextrin, to adsorb or collect odor components on the surface, or to use a solvent or interface with a high boiling point. It is a method of removing odor substances by absorption by an activator, etc., and coating with liquid paraffin, higher alcohol, synthetic resin, etc.
- the biochemical removal method is a method of removing odors by blocking the generation of odor components by bacteria by sterilization by cationic surfactants and disinfectants, or by decomposing organic acids, which are odor components, using digestive enzymes, bacteria, yeast, etc.
- the sensory deodorization method is a method of removing odors by masking with odors that neutralize or offset odors by using a directional incense burner for a target odor component.
- inorganic complexes are known to have excellent sterilization ability to sterilize fungi and viruses including bacteria while being harmless to the human body.
- the inorganic complex compound has a disadvantage in that it cannot act in a place where there is no ultraviolet or sunlight as it requires ultraviolet or sunlight to act in spite of its excellent antibacterial effect.
- nano silver or silver ions or TiO 2 particles having an anatase crystal structure were used to impart an antibacterial function.
- Silver ions have a problem in that, when chlorine ions are contained in water, the chlorine ions form chloride with silver ions and precipitate, and the antibacterial effect disappears.
- TiO 2 particles of anatase crystal structure require ultraviolet light The effect appears, and there are problems such as decomposing the hair material by forming radicals under ultraviolet light and generating other harmful substances.
- Organic compounds such as PHMG, PGH, and CMIT-MIT used as humidifier disinfectants were used a lot as a method of imparting an antibacterial function using an organic system.
- the present invention has been devised to solve the above problems, an object of the present invention is to solve the above problems, and an object of the present invention is a surface modified to have deodorizing, antibacterial and antiviral functions An object of the present invention is to provide a fiber comprising a, and a manufacturing method and processing apparatus thereof.
- the surface of the fiber is a hydroxyl group (-OH), a carboxyl group (-COOH) or Plasma treatment with at least one of peroxy groups (-COOOH) provides functional fibers.
- the fiber is characterized in that the surface is modified with a cold plasma (cold plasma) or thermal plasma (thermal plasma).
- cold plasma cold plasma
- thermal plasma thermal plasma
- the gas used for generating the cold plasma is at least one of argon or neon, and it is characterized in that it further includes moisture and oxygen to promote surface oxidation.
- the gas used for generating the thermal plasma is at least one of liquefied propane gas (LPG) or liquefied natural gas (LNG), characterized in that it further contains moisture and oxygen to promote surface oxidation.
- LPG liquefied propane gas
- LNG liquefied natural gas
- the cold plasma treatment is performed for 1 to 300 seconds, and the thermal plasma treatment is performed for 0.01 to 5 seconds.
- the fiber is polyester (PET), polyethylene (PE), spandex (Spandex), polypropylene (PP), nylon (Nylon), cotton (cotton), acrylic (Acrylic), aramid (Aramid), vinylon (Vinylon) ), Vinyon, Xylon, Rayon, Cashmere, Cellulose, or Basalt, characterized in that at least one type of fiber.
- the present invention provides an apparatus for manufacturing a functional fiber by modifying the surface of a fiber, comprising: a plasma chamber in which a surface modification reaction of the fiber occurs; a plasma processing unit provided inside the plasma chamber to generate a plasma flame; and a bobbin for introducing the fiber into the plasma chamber and discharging it to the outside.
- the plasma chamber is provided with an inlet through which the fiber is introduced and an outlet through which the fiber is discharged, and the surface of the fiber passing through the outlet is a hydroxyl group (-OH), a carboxyl group (-COOH), a peroxy group ( -COOOH) and characterized in that it is modified with one selected from the group consisting of mixtures thereof.
- a gas outlet is provided at one side of the plasma chamber, and the gas outlet is disposed close to the outlet through which the fibers are discharged, so that the plasma flame can flow in one direction.
- the plasma generated in the plasma processing unit is atmospheric pressure cold plasma
- the processing time of the cold plasma is 1 ⁇ 300 seconds
- the internal temperature of the plasma chamber is 10 ⁇ 300 °C
- the internal temperature of the plasma chamber is the fiber It is characterized in that the temperature is lower than the melting point of 5 ⁇ 150 °C.
- the present invention provides a method for producing a functional fiber having a modified surface, the method comprising: preparing a fiber bundle (S10); The step of unwinding the fiber from the fiber bundle and entering the plasma chamber (S20); and a step (S30) of chemically modifying the surface of the fiber by oxidizing the surface of the fiber through the plasma processing unit of the entry portion of the plasma chamber;
- the plasma generated in the plasma processing unit is atmospheric pressure cold plasma
- the processing time of the cold plasma is 1 ⁇ 300 seconds
- the internal temperature of the plasma chamber is 10 ⁇ 300 °C
- the internal temperature of the plasma chamber is the fiber It is characterized in that the temperature is lower than the melting point of 5 ⁇ 150 °C.
- the functional fiber manufacturing method according to the present invention deodorizes the surface of the fiber by modifying it with at least one functional group of a carboxyl group (-COOH), a hydroxyl group (-OH) and a peroxy group (-COOOH). It is possible to provide fibers with excellent antibacterial and antiviral properties.
- the functional fiber manufacturing method according to the present invention has the advantage of being able to easily and simply impart deodorant, antibacterial and antiviral functions through cold plasma treatment.
- FIG. 1 is a flowchart of a method for manufacturing a surface-modified functional fiber using cold plasma according to a preferred embodiment of the present invention.
- FIG. 2 is a view showing a fiber processing apparatus according to a preferred embodiment of the present invention.
- FIG. 3 is a view showing a fabric processing apparatus according to a preferred embodiment of the present invention.
- fiber (100, fiber) is a solid whose thickness is so thin that it cannot be directly measured with the naked eye and whose length is at least 100 times greater than its diameter or width, and a fiber composed of a fiber and the fiber means yarn.
- cold plasma is a plasma that prevents thermal deformation due to thermal contact in the process process, and consists of glow, corona, balanced arc, dusty, gliding, etc., specifically, It can occur through plasma treatment, plasma grafting and plasma polymerization.
- thermal plasma means a plasma using a combustible gas.
- the surface of the fiber 100 is subjected to cold plasma treatment using the fiber processing apparatus 10 of FIG. (-COOH) or peroxy group (-COOOH) is modified with one or more.
- the fiber 100 has a surface modified with at least one of a hydroxyl group (-OH), a carboxyl group (-COOH), or a peroxy group (-COOOH) by the fiber processing device 10 according to the present invention to deodorize, It has antibacterial and antiviral properties.
- the fiber 100 is suitable to use 10 to 50 denier, according to a preferred embodiment, the fiber 100 uses a fiber of 30 denier. If the fiber 100 is less than 10 denier, the fiber is excessively thin and a large amount of fiber is required when manufacturing a fiber or fabric, resulting in low production efficiency. As a result, the feel and quality of the fibers may be reduced.
- the fiber 100 is polyester (PET), polyethylene (PE), spandex (Spandex), polypropylene (PP), nylon (Nylon), cotton (cotton), acrylic (Acrylic), aramid (Aramid) , Vinylon, Vinyon, Zylon, Rayon, Cashmere, Cellulose, Basalt is at least one type of fiber.
- the surface of the fiber 100 is modified with a cold plasma or a thermal plasma.
- the fiber 100 When the surface is modified through the cold plasma, the fiber 100, it is appropriate to use an oxidizing gas, and when using the oxidizing gas water vapor (H 2 O) and oxygen plasma, water vapor and oxygen plasma It is adsorbed to the surface and has a relatively good antibacterial or deodorizing function.
- oxidizing gas water vapor (H 2 O) and oxygen plasma, water vapor and oxygen plasma It is adsorbed to the surface and has a relatively good antibacterial or deodorizing function.
- the cold plasma treatment according to the inert gas mainly consists of physical surface modification, and in the case of water vapor and oxygen having oxidizing properties, chemical surface modification is mainly performed, so that the process may be different.
- the chemical surface modification causes a reaction such as PH (polymer) + O ⁇ P ⁇ + ⁇ OH by chemical action of oxygen atoms in addition to ion bombardment, and it can be seen that it is more advantageous than the case of physical surface modification.
- the generated radicals may remain in an isolated state, or radicals may react with each other to form crosslinks, and may be exposed to air to generate polar groups such as hydroxyl groups and carbonyl groups.
- the cold plasma can overcome the conventional problem of changing the physical properties of the fiber itself, and as the surface of the fiber is modified to a micro depth, the overall physical properties are not changed, and deodorizing, antibacterial and antiviral functions are achieved. can be given
- the surface of the fiber when the fiber 100 is subjected to cold plasma treatment, the surface of the fiber may be maintained super-hydrophilic for a long time, and the hydrophobic surface may be modified into a hydrophilic surface without additional light irradiation.
- the cold plasma may be carried out in a vacuum or atmospheric pressure state, and preferably in an atmospheric pressure state.
- the cold plasma is atmospheric pressure cold plasma, it is a technology for generating cold plasma while maintaining the gas pressure from 100 Torr to 760 Torr (atmospheric pressure) or more, and there is no need for a separate vacuum system, so the investment cost in the device can be reduced. , there is no separate pumping time, and since the in-line process is possible, productivity can be maximized, and it can be appropriately used to modify the surface of a conventional material.
- the cold plasma is a vacuum cold plasma
- it is a technology to generate a cold plasma by maintaining the gas pressure below 100 Torr.
- the cold plasma treatment is suitably performed for 1 second or more, and is preferably performed for 1 to 300 seconds.
- the cold plasma is performed for less than 1 second, the cold plasma is not properly treated, so the surface modification of the fiber may not be uniform. there is a problem with
- the thermal plasma treatment is preferably performed for 0.01 seconds or more, and the temperature at which the thermal plasma is instantaneously applied to the surface is preferably set to 1,000° C. or more. At this time, when the instantaneous temperature applied to the surface is less than 1,000° C., this is because the surface of the fiber is non-uniformly modified.
- the fiber 100 may be configured to include inorganic nanoparticles in order to increase the deodorizing and antibacterial functions.
- the inorganic nanoparticles are silicon nanoparticles, germanium nanoparticles, zinc oxide, magnesium oxide, aluminum oxide, SiOx (0 ⁇ x ⁇ 2), GeOx (0 ⁇ x ⁇ 2) at least one compound selected from the group consisting of can be done
- the cold plasma-treated surface of the organic fiber 100 is modified with one or more of a hydroxyl group (-OH), a carboxyl group (-COOH), or a peroxy group (-COOOH) as shown in Scheme 1 below.
- the combination of a carboxyl group and a hydroxyl group contributes to deodorization
- the combination of a carboxyl group, a hydroxyl group and a peroxy group contributes to antibacterial activity.
- the cold plasma-treated surface of the inorganic fiber 100 may be represented by the following Reaction Equation 2.
- the hydroxyl group and the oxidized functional group contribute to deodorization, and the peroxidized group contributes to the deodorization, antibacterial and antiviral.
- the fiber or fabric when the fiber or fabric is subjected to cold plasma treatment, a functional functional group is introduced into the fiber surface, and the antibacterial, deodorizing and antiviral function of the fiber can be increased through the cold plasma treatment.
- FIG. 1 is a flowchart of a method for manufacturing a functional fiber whose surface is modified by using cold plasma according to a preferred embodiment of the present invention.
- the method for producing a functional fiber comprises the steps of (S10) preparing a fiber bundle; (S20) the step of unwinding the fiber from the fiber bundle and entering the plasma chamber; and (S30) chemically modifying the surface of the fiber by oxidizing the surface of the fiber through the plasma processing unit at the entry portion of the plasma chamber.
- the step of preparing the fiber bundle (S10) is a pre-step of preparing the fiber 100 to be modified on the surface, and by preparing the fiber 100 in a bundle state, the fiber 100 is unwound by the fiber processing apparatus It is easy to inflow and discharge into (10).
- the fiber is unwound from the fiber bundle and enters the plasma chamber (S20).
- the fiber 100 in the bundle state is unwound while rotating, and the plasma chamber ( 13) Enter inside.
- the surface of the fiber is oxidized and chemically modified through a plasma processing unit that is provided inside the plasma chamber to generate a plasma flame.
- the plasma generated in the plasma processing unit 11 is atmospheric pressure cold plasma, the processing time of the cold plasma is 1 to 300 seconds, and the internal temperature of the plasma chamber 13 is 10 to 300° C., and the inside of the plasma chamber It is preferable that the temperature is 5 ⁇ 150 °C lower than the melting point of the fiber.
- the plasma processing unit 11 is a high-frequency induction heat plasma, using a frequency of 13.56 MHz, which is a common frequency, and using the plasma processing unit at atmospheric pressure, high-purity oxygen (O 2 , 99%) 200 sccm A cold plasma treatment is performed in the plasma chamber 13 by generating plasma while putting the .
- Figure 2 is a view showing a fiber processing apparatus 10 according to a preferred embodiment of the present invention.
- the fiber processing apparatus 10 of the present invention includes a plasma processing unit 11 , a plasma chamber 13 , a gas outlet 15 , and a bobbin 17 .
- the plasma processing unit 11 generates a plasma flame 12 to perform plasma processing, is provided in the plasma chamber 13, and the fiber processing device 10 includes one or more of the plasma processing units 11 it is preferable
- the plasma processing unit 11 is installed to provide a plasma flame 12 inside the plasma chamber 13 in one direction, and the plasma processing unit 11 is an inlet (not shown) through which the fiber 100 is introduced. It is preferable to be arranged close to the side.
- the plasma processing unit 11 is installed to have an angle of 0 to 75° with the advancing direction of the fiber 100 to generate a plasma flame 12 in the advancing direction of the fiber 100 .
- the plasma processing unit 11 is installed to have an angle of 70° with the moving direction of the fiber 100 so that a wide spatula can be modified at once.
- the plasma processing unit 11 may generate a cold plasma or a thermal plasma, and when the plasma processing unit 11 generates a cold plasma, the gas used is at least one of argon or neon, to promote surface oxidation of fibers It may further contain moisture and oxygen.
- the plasma processing unit 11 provides a plasma flame 12 using one or more of argon or neon for cold plasma generation at a low temperature, whereby the surface of the fiber 100 is oxidized and hydroxyl groups ( -OH), a carboxyl group (-COOH), or a peroxy group (-COOOH) to generate a functional group.
- the gas used is either liquefied propane gas (LPG) or liquefied natural gas (LNG), and may further include moisture and oxygen to promote surface oxidation.
- LPG liquefied propane gas
- LNG liquefied natural gas
- the cold plasma treatment is performed for 1 to 300 seconds, and the thermal plasma treatment is preferably performed for 0.01 to 5 seconds.
- the plasma chamber 13 is preferably provided with oxygen, ozone, water, etc. in order to oxidize the surface of the fiber in the plasma chamber 13 .
- the internal temperature of the plasma chamber 13 may be different depending on the type of the fiber used, and the internal temperature of the plasma chamber 13 may be lower than the melting point of the fiber.
- the internal temperature of the plasma chamber 13 may be set in the range of 10 to 300° C. in order to process the cold plasma, and according to a preferred embodiment, the internal temperature of the plasma chamber 13 and the melting point of the fiber are 5 A temperature as low as ⁇ 150°C is appropriate. If it is out of the above range, it may be difficult to efficiently modify the fiber surface, and damage to the fiber may occur.
- the internal temperature of the plasma chamber 13 is set to be lower than the melting point of the fiber 100 by 75° C., so that the surface of the fiber 100 in the plasma chamber can be modified at an appropriate rate.
- the surface of the fiber 100 outside the outlet (not shown) of the plasma chamber 13 is at least one of a hydroxyl group (-OH), a carboxy group (-COOH), or a peroxy group (-COOOH) includes
- the plasma chamber 13 is provided with an inlet (not shown) through which the fiber 100 is introduced and an outlet (not shown) through which the fiber 100 is discharged.
- the plasma chamber 13 includes an inlet (not shown) formed at the front end and an outlet (not shown) formed at the rear end so that the fiber 100 can pass through the interior.
- the surface of the fiber passing through the outlet (not shown) is modified with one or more of a hydroxyl group (-OH), a carboxyl group (-COOH), or a peroxy group (-COOOH).
- a gas outlet 15 is provided at one side of the plasma chamber 13, and the gas outlet 15 is disposed closer to an outlet (not shown) through which the fiber 100 is discharged than the plasma processing unit 13 is. It allows the plasma flame 12 to flow in one direction.
- the bobbin 17 introduces the fiber 100 into the plasma chamber 13 and discharges it to the outside, and the fiber processing apparatus 10 includes one or more bobbins 17 . It is preferable
- the bobbin 17 makes it possible to continuously process the fiber 100 by rotation, and since plasma treatment is continuously performed, a carboxyl group (-COOH), a hydroxyl group (- OH) and peroxy group (-COOOH) may be uniformly generated.
- Figure 3 is a view showing a fabric processing apparatus according to a preferred embodiment of the present invention.
- the fabric processing apparatus 30 of the present invention includes a plasma processing unit 31 , a plasma chamber 33 , a gas outlet 35 , and a bobbin 37 .
- the term “textile” refers to a fabric having a flat body of a predetermined width by intersecting warp and weft yarns up and down, and the fabric 300 includes the fiber or the fiber yarn ( yarn) can be woven.
- the fabric processing apparatus 30 of the present invention is similar to the textile processing apparatus 10, but an inlet (not shown) of the textile processing apparatus 30 so that the textile 300 can pass through the inside of the plasma chamber 33 .
- the outlet (not shown) has a different shape from the inlet and outlet of the fiber processing apparatus 10 .
- the plasma chamber 33 is formed in a rectangular parallelepiped shape.
- the fabric processing apparatus 30 is provided with a gas outlet 35 at one side of the plasma chamber 33 , and the gas outlet 35 is disposed close to an outlet (not shown) through which the fabric is discharged.
- the plasma flame 32 can flow in one direction.
- a plasma processing unit 31 generating a plasma flame 32 is provided inside the plasma chamber 33 .
- the plasma processing unit 31 provides a plasma flame 32 on the front side of the textile 300 so that a part of the plasma processing unit 31 is provided for plasma processing on the front and back surfaces of the fabric 300 . and the remainder of the plasma treatment section 31 is arranged to provide a plasma flame 32 to the back side of the fabric 300 .
- the surface of the fabric 300 is subjected to cold plasma treatment using the fabric treatment device 30 of FIG. 3, the fabric 300
- the surface is modified with at least one of a hydroxy group (-OH), a carboxy group (-COOH), or a peroxy group (-COOOH).
- the internal temperature of the plasma chamber 33 may be set in the range of 10 to 300° C., but is preferably set lower by 5 to 50° C. than the melting point of the fabric 300 .
- the internal temperature of the plasma chamber 33 is set lower than the melting point of the fabric 300 by 25° C. to modify the surface of the fabric 300 at an appropriate rate.
- the fabric 300 may be configured to include inorganic nanoparticles.
- the inorganic nanoparticles are silicon nanoparticles, germanium nanoparticles, zinc oxide, magnesium oxide, aluminum oxide, SiOx (0 ⁇ x ⁇ 2), GeOx (0 ⁇ x ⁇ 2) consisting of at least one compound selected from the group consisting of can
- the surface of the cold plasma-treated fabric 300 is modified with a carboxyl group (-COOH) and a hydroxyl group (-OH) as shown in Scheme 4, or a peroxy group, a carboxyl group and a hydroxyl group as shown in Scheme 5 below.
- a carboxyl group and a hydroxyl group contributes to deodorization
- the combination of a carboxyl group, a hydroxyl group and a peroxy group contributes to antibacterial activity.
- Plasma is a high-frequency induction heat plasma using a frequency of 13.56 MHz, and using a plasma processing unit at atmospheric pressure, high-purity oxygen (O 2 , 99%) 200 sccm was put into the plasma, and cold plasma treatment was performed in the plasma chamber.
- the fiber yarn is a 30 denier PET fiber yarn, and the PET fiber is treated with cold oxygen plasma for 0 sec (control), 0.1 sec, 1 sec, 5 sec, 30 sec, and 60 sec, and the surface of the fiber is chemically modified, Accordingly, it was prepared as a functional fiber.
- a 30 denier PE fiber yarn was used, and it was prepared in the same manner as in Example 1.
- the Experimental Example 1 is to evaluate the deodorizing performance of the fiber, and Examples 1 to 16 were put in a Tedlar bag of 1L capacity, respectively, and 100 ppm of ammonia was added to the inside of the Tedlar bag at an internal humidity of 50 ⁇ 5%. It was added as much as possible, and after 1 hour, the deodorization rate of ammonia in the Tedlar bag was analyzed to obtain the results in Table 1.
- the Experimental Example 2 is to evaluate the deodorizing performance of the fibers, and Examples 1 to 16 were put in a Tedlar bag of 1L capacity, respectively, and 100 ppm of acetic acid was added to the inside of the Tedlar bag at an internal humidity of 50 ⁇ 5%. It was added as much as possible, and after 1 hour, the deodorization rate of acetic acid in the Tedlar bag was analyzed, and the results shown in Table 2 were obtained.
- Example 1 14 65 99 99 99 5% or less Example 2 12 73 99 99 99 5% or less Example 3 10 70 99 99 99 5% or less Example 4 11 82 99 99 99 5% or less Example 5 12 80 99 99 99 5% or less Example 6 34 99 99 99 99 25% or less Example 7 11 75 99 99 99 5% or less Example 8 13 77 99 99 99 5% or less Example 9 22 76 99 99 99 5% or less Example 10 20 73 99 99 99 5% or less Example 11 19 72 99 99 99 5% or less Example 12 16 75 99 99 99 5% or less Example 13 15 75 99 99 99 5% or less Example 14 36 99 99 99 99 below 10 Example 15 40 99 99 99 99 below 10 Example 16 18 70 99 99 99 5% or less
- Experimental Example 3 is to evaluate the antibacterial performance of the fiber, and Examples 1 to 16 were measured for antibacterial performance against bacteria A (Staphylococcus aureus ATCC 6538) according to the test method of KS K ISO 0693:2016. was expressed as the bacteriostatic reduction rate, and the results are shown in Table 3.
- Examples 1 to 16 showed a sharp increase in the bacteriostatic reduction rate of Staphylococcus aureus, the bacterium A. In particular, when the cold plasma treatment time is 5 seconds, it can be confirmed that the bacteriostatic reduction rate of 80% or more. In addition, Examples 1 to 16 have excellent antibacterial activity compared to the same fiber (control group) not subjected to cold plasma, and it is preferable that the cold plasma treatment time for the antibacterial function is set to at least 5 seconds or more.
- Example 4 Evaluation of antibacterial performance of fibers
- the Experimental Example 4 is to evaluate the antibacterial performance of the fiber, and Examples 1 to 16 according to the test method of KS K ISO 0693:2016 by measuring the antibacterial performance against Bacteria B (Pneumococcus, Klebsiella neumoniae ATCC 4352) It was expressed as a bacteriostatic reduction rate, and the results are shown in Table 4.
- Plasma is a high-frequency induction heat plasma, using a frequency of 13.56 MHz, and using a plasma processing unit at atmospheric pressure to generate plasma while putting 200 sccm of high-purity oxygen (O 2 , 99%) in the plasma chamber, and cold plasma treatment was performed in the plasma chamber. .
- the fabric uses 30 denier PET fabric and is treated with cold oxygen plasma for 0 sec (control), 0.1 sec, 1 sec, 5 sec, 30 sec, and 60 sec. was prepared with
- the Experimental Example 5 is to evaluate the deodorization performance of the fabric, and Examples 17 to 22 were put in a Tedlar bag of 1L capacity, respectively, and 100ppm of ammonia inside the Tedlar bag at 50 ⁇ 5% internal humidity. After 1 hour, the results of Table 5 were obtained by analyzing the deodorization rate of ammonia inside the Tedlar bag.
- Examples 17 to 22 can confirm that the deodorization performance is increased, in particular, when the cold plasma is 1 second, carried out It can be seen that the deodorization rate of Examples 17 to 22 is remarkably high. Therefore, the cold plasma treatment time for the deodorizing function is preferably set to at least 1 second or more.
- Experimental Example 6 Evaluation of deodorization performance of fabrics
- the Experimental Example 6 is for evaluating the deodorizing performance of the fabric, and Examples 17 to 22 were put in a Tedlar bag of 1L capacity, respectively, and 100 ppm of acetic acid was added to the inside of the Tedlar bag at an internal humidity of 50 ⁇ 5%. It was added as much as possible, and after 1 hour, the deodorization rate of acetic acid inside the Tedlar bag was analyzed to obtain the results in Table 6.
- Experimental Example 7 is for evaluating the antibacterial performance of the fabric, and Examples 17 to 22 were measured for antibacterial performance against bacteria A (Staphylococcus aureus ATCC 6538) according to the test method of KS K ISO 0693:2016. was expressed as the bacteriostatic reduction rate, and the results are shown in Table 7.
- the cold plasma treatment time for the antibacterial function is preferably set to at least 5 seconds or more.
- Experimental Example 8 is to evaluate the antibacterial performance of the fabric, and Examples 17 to 22 were measured by measuring the antibacterial performance against Bacteria B (Klebsiella pneumoniae ATCC 4352) according to the test method of KS K ISO 0693:2016. It was expressed as a bacteriostatic reduction rate, and the results are shown in Table 8.
- Examples 17 to 22 can confirm that the antibacterial performance is increased, in particular, when the plasma treatment time is 5 seconds, 90 %, and when the plasma treatment time is 30 seconds, the antibacterial rate is 99%, so it can be confirmed that the antibacterial activity of the cold plasma-treated fabric is excellent for 5 seconds or more.
- Experimental Example 9 Evaluation of antiviral performance of fibers
- Experimental Example 9 is to evaluate the antiviral performance of the fiber, and Examples 17 to 22 according to the test method of ASTM E1052-11 Human Influenza A (H1N1), host cell MDCK (NBL-2), ATCC CCL- By measuring the antiviral performance against 34, the bacteriostatic reduction rate was converted to a Lod reduction value, and the results are shown in Table 9.
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Plasma & Fusion (AREA)
- Textile Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Business, Economics & Management (AREA)
- Emergency Management (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
Abstract
Description
암모니아 소취율(%) |
플라즈마 처리 시간(초) | 대조군 |
||||
0.1 | 1 | 5 | 30 | 60 | ||
실시예 1 | 12 | 80 | 99 | 99 | 99 | 5%이하 |
실시예 2 | 11 | 75 | 99 | 99 | 99 | 5%이하 |
실시예 3 | 10 | 78 | 99 | 99 | 99 | 5%이하 |
실시예 4 | 9 | 85 | 99 | 99 | 99 | 5%이하 |
실시예 5 | 13 | 80 | 99 | 99 | 99 | 5%이하 |
실시예 6 | 45 | 99 | 99 | 99 | 99 | 35%이하 |
실시예 7 | 13 | 85 | 99 | 99 | 99 | 5%이하 |
실시예 8 | 15 | 84 | 99 | 99 | 99 | 5%이하 |
실시예 9 | 25 | 80 | 99 | 99 | 99 | 5%이하 |
실시예 10 | 23 | 86 | 99 | 99 | 99 | 5%이하 |
실시예 11 | 21 | 83 | 99 | 99 | 99 | 5%이하 |
실시예 12 | 18 | 84 | 99 | 99 | 99 | 5%이하 |
실시예 13 | 18 | 82 | 99 | 99 | 99 | 5%이하 |
실시예 14 | 38 | 99 | 99 | 99 | 99 | 10%이하 |
실시예 15 | 42 | 99 | 99 | 99 | 99 | 10%이하 |
실시예 16 | 20 | 86 | 99 | 99 | 99 | 5%이하 |
아세트산 소취율(%) |
플라즈마 처리 시간(초) | 대조군 |
||||
0.1 | 1 | 5 | 30 | 60 | ||
실시예 1 | 14 | 65 | 99 | 99 | 99 | 5%이하 |
실시예 2 | 12 | 73 | 99 | 99 | 99 | 5%이하 |
실시예 3 | 10 | 70 | 99 | 99 | 99 | 5%이하 |
실시예 4 | 11 | 82 | 99 | 99 | 99 | 5%이하 |
실시예 5 | 12 | 80 | 99 | 99 | 99 | 5%이하 |
실시예 6 | 34 | 99 | 99 | 99 | 99 | 25%이하 |
실시예 7 | 11 | 75 | 99 | 99 | 99 | 5%이하 |
실시예 8 | 13 | 77 | 99 | 99 | 99 | 5%이하 |
실시예 9 | 22 | 76 | 99 | 99 | 99 | 5%이하 |
실시예 10 | 20 | 73 | 99 | 99 | 99 | 5%이하 |
실시예 11 | 19 | 72 | 99 | 99 | 99 | 5%이하 |
실시예 12 | 16 | 75 | 99 | 99 | 99 | 5%이하 |
실시예 13 | 15 | 75 | 99 | 99 | 99 | 5%이하 |
실시예 14 | 36 | 99 | 99 | 99 | 99 | 10%이하 |
실시예 15 | 40 | 99 | 99 | 99 | 99 | 10%이하 |
실시예 16 | 18 | 70 | 99 | 99 | 99 | 5%이하 |
세균 A 정균감소율(%) |
플라즈마 처리 시간(초) | 대조군 |
||||
0.1 | 1 | 5 | 30 | 60 | ||
실시예 1 | 10 | 23 | 82 | 99 | 99 | 10%이하 |
실시예 2 | 9 | 21 | 79 | 99 | 99 | 10%이하 |
실시예 3 | 10 | 33 | 80 | 99 | 99 | 10%이하 |
실시예 4 | 12 | 30 | 86 | 99 | 99 | 10%이하 |
실시예 5 | 13 | 26 | 83 | 99 | 99 | 10%이하 |
실시예 6 | 13 | 35 | 95 | 99 | 99 | 10%이하 |
실시예 7 | 12 | 37 | 98 | 99 | 99 | 10%이하 |
실시예 8 | 15 | 40 | 99 | 99 | 99 | 10%이하 |
실시예 9 | 16 | 25 | 95 | 99 | 99 | 10%이하 |
실시예 10 | 17 | 23 | 92 | 99 | 99 | 10%이하 |
실시예 11 | 19 | 21 | 83 | 99 | 99 | 10%이하 |
실시예 12 | 18 | 34 | 89 | 99 | 99 | 10%이하 |
실시예 13 | 11 | 29 | 96 | 99 | 99 | 10%이하 |
실시예 14 | 18 | 38 | 99 | 99 | 99 | 10%이하 |
실시예 15 | 22 | 35 | 99 | 99 | 99 | 10%이하 |
실시예 16 | 21 | 45 | 94 | 99 | 99 | 10%이하 |
세균 B 정균감소율(%) |
플라즈마 처리 시간(초) | 대조군 |
||||
0.1 | 1 | 5 | 30 | 60 | ||
실시예 1 | 13 | 32 | 87 | 99 | 99 | 10%이하 |
실시예 2 | 11 | 31 | 89 | 99 | 99 | 10%이하 |
실시예 3 | 16 | 30 | 90 | 99 | 99 | 10%이하 |
실시예 4 | 13 | 31 | 89 | 99 | 99 | 10%이하 |
실시예 5 | 12 | 27 | 93 | 99 | 99 | 10%이하 |
실시예 6 | 23 | 29 | 96 | 99 | 99 | 10%이하 |
실시예 7 | 22 | 32 | 99 | 99 | 99 | 10%이하 |
실시예 8 | 23 | 38 | 99 | 99 | 99 | 10%이하 |
실시예 9 | 19 | 26 | 95 | 99 | 99 | 10%이하 |
실시예 10 | 13 | 39 | 93 | 99 | 99 | 10%이하 |
실시예 11 | 29 | 41 | 96 | 99 | 99 | 10%이하 |
실시예 12 | 20 | 34 | 92 | 99 | 99 | 10%이하 |
실시예 13 | 17 | 38 | 96 | 99 | 99 | 10%이하 |
실시예 14 | 16 | 36 | 99 | 99 | 99 | 10%이하 |
실시예 15 | 19 | 32 | 99 | 99 | 99 | 10%이하 |
실시예 16 | 23 | 36 | 99 | 99 | 99 | 10%이하 |
암모니아 소취율(%) |
플라즈마 처리 시간(초) | 대조군 | ||||
0.1 | 1 | 5 | 30 | 60 | ||
실시예 17 | 10 | 65 | 99 | 99 | 99 | 5%이하 |
실시예 18 | 11 | 64 | 99 | 99 | 99 | 5%이하 |
실시예 19 | 11 | 66 | 99 | 99 | 99 | 5%이하 |
실시예 20 | 13 | 68 | 99 | 99 | 99 | 5%이하 |
실시예 21 | 10 | 70 | 99 | 99 | 99 | 5%이하 |
실시예 22 | 11 | 72 | 99 | 99 | 99 | 35%이하 |
아세트산 소취율(%) |
플라즈마 처리 시간(초) | 대조군 | ||||
0.1 | 1 | 5 | 30 | 60 | ||
실시예 17 | 13 | 75 | 99 | 99 | 99 | 5%이하 |
실시예 18 | 12 | 73 | 99 | 99 | 99 | 5%이하 |
실시예 19 | 9 | 75 | 99 | 99 | 99 | 5%이하 |
실시예 20 | 12 | 78 | 99 | 99 | 99 | 5%이하 |
실시예 21 | 10 | 69 | 99 | 99 | 99 | 5%이하 |
실시예 22 | 14 | 72 | 99 | 99 | 99 | 35%이하 |
세균 A 정균감소율 (%) |
플라즈마 처리 시간(초) | 대조군 | ||||
0.1 | 1 | 5 | 30 | 60 | ||
실시예 17 | 15 | 41 | 83 | 99 | 99 | 10%이하 |
실시예 18 | 17 | 39 | 82 | 99 | 99 | 10%이하 |
실시예 19 | 18 | 43 | 83 | 99 | 99 | 10%이하 |
실시예 20 | 14 | 42 | 85 | 99 | 99 | 10%이하 |
실시예 21 | 18 | 59 | 90 | 99 | 99 | 10%이하 |
실시예 22 | 23 | 42 | 92 | 99 | 99 | 10%이하 |
세균 B 정균감소율 (%) |
플라즈마 처리 시간(초) | 대조군 | ||||
0.1 | 1 | 5 | 30 | 60 | ||
실시예 17 | 13 | 35 | 83 | 99 | 99 | 10%이하 |
실시예 18 | 14 | 43 | 90 | 99 | 99 | 10%이하 |
실시예 19 | 18 | 50 | 87 | 99 | 99 | 10%이하 |
실시예 20 | 12 | 53 | 89 | 99 | 99 | 10%이하 |
실시예 21 | 22 | 59 | 91 | 99 | 99 | 10%이하 |
실시예 22 | 20 | 53 | 90 | 99 | 99 | 10%이하 |
Human Influenza A (H1N1) |
플라즈마 처리 시간(초) | 대조군 | ||||
0.1 | 1 | 5 | 30 | 60 | ||
실시예 17 | 0.5 | 1.2 | 2.1 | 3.1 | 5.2 | 10%이하 |
실시예 18 | 0.4 | 1.1 | 2.3 | 3.5 | 5.1 | 10%이하 |
실시예 19 | 0.5 | 1.2 | 2.6 | 3.7 | 5.5 | 10%이하 |
실시예 20 | 0.6 | 1.1 | 2.2 | 3.3 | 5.2 | 10%이하 |
실시예 21 | 0.5 | 1.0 | 2.1 | 3.0 | 4.7 | 10%이하 |
실시예 22 | 0.4 | 1.1 | 2.2 | 3.2 | 5.0 | 10%이하 |
Claims (12)
- 소취, 항균 및 항바이러스 기능의 섬유에 있어서,상기 섬유의 표면은 하이드록시기(-OH), 카르복시기(-COOH) 또는 퍼옥시기(-COOOH) 중 1종 이상으로 플라즈마 처리되어 개질된 기능성 섬유.
- 제 1항에 있어서,상기 섬유는 콜드 플라즈마(cold plasma) 또는 열 플라즈마(thermal plasma)로 표면이 개질되는 것을 특징으로 하는 기능성 섬유.
- 제 2항에 있어서,상기 콜드 플라즈마 발생에 사용되는 가스는 아르곤 또는 네온 중 1종 이상이며,표면 산화를 촉진시키기 위해 수분 및 산소를 더 포함하는 것을 특징으로 하는 기능성 섬유.
- 제 2항에 있어서,상기 열 플라즈마 발생에 사용되는 가스는 액화프로판가스(LPG) 또는 액화천연가스(LNG) 중 1종 이상이며,표면 산화를 촉진시키기 위해 수분 및 산소를 더 포함하는 것을 특징으로 하는 기능성 섬유.
- 제 2항에 있어서,상기 콜드 플라즈마 처리는 1~300초 수행되며,상기 열 플라즈마 처리는 0.01~5초 수행되는 것을 특징으로 하는 기능성 섬유.
- 제 1항에 있어서,상기 섬유는 폴리에스터(PET), 폴리에틸렌(PE), 스판덱스(Spandex), 폴리프로필렌(PP), 나일론(Nylon), 면(cotton), 아크릴(Acrylic), 아라미드(Aramid), 비닐론(Vinylon), 비니온(Vinyon), 자일론(Zylon), 인견(Rayon), 캐시미어(Cashmere), 셀룰로스(Cellulose), 또는 현무암(Basalt) 중 1종 이상의 섬유인 것을 특징으로 하는 기능성 섬유.
- 섬유의 표면을 개질하여 기능성 섬유를 제조하는 장치에 있어서,상기 섬유의 표면개질 반응이 발생하는 플라즈마 챔버;상기 플라즈마 챔버 내부에 구비되어 플라즈마 불꽃이 발생하는 플라즈마 처리부; 및상기 섬유를 플라즈마 챔버 내부로 유입시켜 외부로 배출시키는 보빈;을 포함하는 기능성 섬유의 제조장치.
- 제 7항에 있어서,상기 플라즈마 챔버는 상기 섬유가 유입되는 유입구와 상기 섬유가 배출되는 배출구가 구비되며,상기 배출구를 통과한 상기 섬유의 표면은 하이드록시기(-OH), 카르복시기(-COOH), 퍼옥시기(-COOOH) 및 이의 혼합으로 이루어진 군에서 선택된 하나로 개질된 것을 특징으로 하는 기능성 섬유의 제조장치.
- 제 7항에 있어서,상기 플라즈마 챔버 일측에는 가스 배출구가 구비되며,상기 가스 배출구는 상기 섬유가 배출되는 배출구에 가깝게 배치되어 상기 플라즈마 불꽃이 한 방향으로 흐를 수 있는 것을 특징으로 하는 기능성 섬유의 제조장치.
- 제 7항에 있어서,상기 플라즈마 처리부에서 발생하는 플라즈마는 대기압 콜드 플라즈마이며,상기 콜드 플라즈마의 처리시간은 1~300초이고,상기 플라즈마 챔버의 내부온도가 10~300℃이고,상기 플라즈마 챔버의 내부온도가 상기 섬유의 녹는점보다 5~150℃ 낮은 온도인 것을 특징으로 하는 기능성 섬유의 제조장치.
- 표면이 개질된 기능성 섬유의 제조방법에 있어서,섬유 다발을 준비하는 단계(S10);상기 섬유 다발로부터 섬유가 권출되어 플라즈마 챔버 내로 진입하는 단계(S20); 및상기 플라즈마 챔버의 진입 부분의 플라즈마 처리부를 통해 상기 섬유의 표면이 산화되어 화학적으로 표면이 개질되는 단계(S30);를 포함하는 기능성 섬유의 제조방법.
- 제 11항에 있어서,상기 플라즈마 처리부에서 발생하는 플라즈마는 대기압 콜드 플라즈마이며,상기 콜드 플라즈마의 처리시간은 1~300초이고,상기 플라즈마 챔버의 내부온도가 10~300℃이고,상기 플라즈마 챔버의 내부온도가 상기 섬유의 녹는점보다 5~150℃ 낮은 온도인 것을 특징으로 하는 기능성 섬유의 제조방법.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2020-0073953 | 2020-06-17 | ||
KR20200073953 | 2020-06-17 | ||
KR10-2021-0037427 | 2021-03-23 | ||
KR1020210037427A KR102679336B1 (ko) | 2020-06-17 | 2021-03-23 | 기능성 섬유 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021256826A1 true WO2021256826A1 (ko) | 2021-12-23 |
Family
ID=79176050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2021/007463 WO2021256826A1 (ko) | 2020-06-17 | 2021-06-15 | 기능성 섬유 제조방법 |
Country Status (2)
Country | Link |
---|---|
KR (2) | KR102679336B1 (ko) |
WO (1) | WO2021256826A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114806295A (zh) * | 2022-03-21 | 2022-07-29 | 武汉理工大学 | 高温高湿高盐环境下耐候的隔热涂料及隔热保温结构 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0698300B2 (ja) * | 1986-06-13 | 1994-12-07 | 株式会社山東鐵工所 | 低温プラズマ処理装置 |
JPH10259521A (ja) * | 1997-03-21 | 1998-09-29 | Teijin Ltd | 消臭性繊維製品 |
KR20050117922A (ko) * | 2004-06-11 | 2005-12-15 | 주식회사 맥스플라즈마 | 광촉매를 이용한 항균처리방법 |
JP2008285787A (ja) * | 2007-05-18 | 2008-11-27 | Toray Ind Inc | 抗菌繊維構造物の製造方法 |
US20130108805A1 (en) * | 2011-11-02 | 2013-05-02 | Sheila Shahidi | Method of preparation of multifunctional technical textile by plasma-treatment |
KR20200086209A (ko) * | 2019-01-08 | 2020-07-16 | 주식회사 쇼나노 | 저온 플라즈마 처리하여 표면개질된 기능성 섬유의 제조방법 |
KR20200086199A (ko) * | 2019-01-08 | 2020-07-16 | 류상열 | 콜드 플라즈마를 활용한 기능성 섬유 제조방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100872737B1 (ko) | 2007-08-10 | 2008-12-08 | 주식회사 케이피엠테크 | 금속, 합금 및 세라믹 나노 입자가 진공 증착된 마스터배치 칩을 이용한 항균섬유의 제조방법 |
JP6098300B2 (ja) * | 2013-03-29 | 2017-03-22 | 株式会社ニデック | 眼科装置 |
JP6777909B2 (ja) * | 2016-04-20 | 2020-10-28 | 康男 小澤 | 表面改質処理材料の製造方法、および表面改質処理材料の製造装置 |
-
2021
- 2021-03-23 KR KR1020210037427A patent/KR102679336B1/ko active IP Right Grant
- 2021-06-15 WO PCT/KR2021/007463 patent/WO2021256826A1/ko active Application Filing
-
2024
- 2024-02-20 KR KR1020240024583A patent/KR20240041879A/ko not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0698300B2 (ja) * | 1986-06-13 | 1994-12-07 | 株式会社山東鐵工所 | 低温プラズマ処理装置 |
JPH10259521A (ja) * | 1997-03-21 | 1998-09-29 | Teijin Ltd | 消臭性繊維製品 |
KR20050117922A (ko) * | 2004-06-11 | 2005-12-15 | 주식회사 맥스플라즈마 | 광촉매를 이용한 항균처리방법 |
JP2008285787A (ja) * | 2007-05-18 | 2008-11-27 | Toray Ind Inc | 抗菌繊維構造物の製造方法 |
US20130108805A1 (en) * | 2011-11-02 | 2013-05-02 | Sheila Shahidi | Method of preparation of multifunctional technical textile by plasma-treatment |
KR20200086209A (ko) * | 2019-01-08 | 2020-07-16 | 주식회사 쇼나노 | 저온 플라즈마 처리하여 표면개질된 기능성 섬유의 제조방법 |
KR20200086199A (ko) * | 2019-01-08 | 2020-07-16 | 류상열 | 콜드 플라즈마를 활용한 기능성 섬유 제조방법 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114806295A (zh) * | 2022-03-21 | 2022-07-29 | 武汉理工大学 | 高温高湿高盐环境下耐候的隔热涂料及隔热保温结构 |
Also Published As
Publication number | Publication date |
---|---|
KR20240041879A (ko) | 2024-04-01 |
KR20210156204A (ko) | 2021-12-24 |
KR102679336B1 (ko) | 2024-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2021256826A1 (ko) | 기능성 섬유 제조방법 | |
WO2017183781A1 (ko) | 플라즈마 제트를 이용한 복합 소독유체 분무식 멸균장치 및 방법 | |
WO2016140449A1 (en) | Sterilization method and apparatus using the same | |
WO2019066113A1 (ko) | 플렉서블 활성종 발생기 및 이의 용도 | |
US5344462A (en) | Gas plasma treatment for modification of surface wetting properties | |
US20080107822A1 (en) | Treatment of fibrous materials using atmospheric pressure plasma polymerization | |
AU2010322855B2 (en) | Method to shrinkproof wool by plasma polymerization | |
WO2017138743A1 (ko) | 복합 소독유체 분무식 멸균장치 및 방법 | |
US5328576A (en) | Gas plasma treatment for water and oil proofing of fabrics and paper | |
WO2019088735A1 (en) | Hydrogen peroxide sterilization device for sterilization of hospital operating room | |
JP3260140B2 (ja) | 重合体状材料からなる支持体に接着させる酸化珪素の薄層を沈着させる方法 | |
WO2021251705A1 (ko) | 환기형 공기청정기 및 이의 운전방법 | |
KR960004372B1 (ko) | 정밀광학장치 또는 정밀광학부품을 유해물 방출없이 세정하는 방법 | |
WO2023043060A1 (ko) | 플라즈마 처리 장치 | |
WO2022050793A1 (ko) | 실내 공기 살균 및 정화 장치 | |
WO2023106471A1 (ko) | 코팅 내구성 및 자외선 내구성이 향상된 항균 또는 항바이러스 필터 | |
WO2021210876A1 (ko) | 인공지능을 활용한 공기정화장치 및 공기정화방법 | |
KR102217824B1 (ko) | 저온 플라즈마 처리하여 표면개질된 기능성 섬유의 제조방법 | |
KR20200086199A (ko) | 콜드 플라즈마를 활용한 기능성 섬유 제조방법 | |
WO2024117377A1 (ko) | 안전 환기 포기 방법 및 장치 | |
WO2022045675A1 (ko) | 지방족 폴리에스터 섬유로 이루어진 공기정화용 웹-필름 필터 및 이의 제조방법 | |
Palaskar et al. | Plasma induced nano-finish for multifunctional properties on cotton fabric | |
JPH05295656A (ja) | コーティング布帛の製造方法 | |
WO2022080606A1 (ko) | 무기 항균제 및 그것의 제조방법 | |
WO2017039339A1 (ko) | 탄화불소 박막의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21825684 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21825684 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC, EPO FORM 1205A DATED 22.01.2024 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21825684 Country of ref document: EP Kind code of ref document: A1 |